Clinical Trial Update: Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus

View source ↗

Summary

Clinical trial update on a study investigating withdrawal of dopamine agonists in patients with invasive prolactinomas involving the cavernous sinus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prolactinoma

Drugs mentioned

• Dopamine agonists (dopamine agonists)

Snippet

Sponsor: Zhebao Wu | Conditions: Invasive Prolactinomas Involving the Cavernous Sinus | Status: UNKNOWN